Yancheng Yu

11PUBLICATIONS
9CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsBiomolecular modelling and designBioinformatic methods developmentBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 23, 2026
Discovery of FYJ-195 as a Highly Potent FLT3 Inhibitor against Multiple Acquired Resistance Mutations in Acute Myeloid Leukemia.

|May 02, 2026
Discovery of CN-3 as a Next-Generation RET Inhibitor Potently Overcoming Multiple Mutations.

|Apr 03, 2026
Discovery of FLC-8 as the First Covalent FLT3 Inhibitor Targeting Cys807 for FLT3 Mutant Acute Myeloid Leukemia.

Zi-Xuan Wang, Xiao-Long Jing, Qian Liu

|Dec 26, 2024
Design, Synthesis, and Biological Evaluation of 3,4-Dihydroisoquinolin-1(2H)-one Derivatives as Protein Arginine Methyltransferase 5 Inhibitors for the Treatment of Non-Hodgkin's Lymphoma.

Qing-Qing Li, Xu Quan, Zi-Xuan Wang

|Dec 02, 2024
Kinase-Bench: Comprehensive Benchmarking Tools and Guidance for Achieving Selectivity in Kinase Drug Discovery.

Tian-Hua Wei, Shuang-Shuang Zhou, Xiao-Long Jing

|Nov 15, 2024
Discovery of 1-(Phenylsulfonyl)-1,2,3,4-tetrahydroquinoline Derivative as Orally Bioavailable and Safe RORγt Inverse Agonists for Potential Treatment of Rheumatoid Arthritis.

Shan-Liang Sun, Hong-Jiang Xu, Xiao-Long Jiang

Pageof 2

Frequent Collaborators

8 joint publications

Nian-Guang Li

6 joint publications

Xin Xue

4 joint publications

Xiao-Long Wang

2 joint publications

Peng Cao